Therapy Areas: Diabetes
22 March 2019 - - US-based ophthalmic pharmaceutical company Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has started patient dosing in its Phase 2 clinical trial designed in accordance with the require...
22 March 2019 - The Mundipharma network of independent associated companies has introduced the type-two diabetes mellitus treatments Invokana (canagliflozin) and Vokanamet (canagliflozin, metformin) i...
21 March 2019 - Global healthcare company Novo Nordisk A/S (CPH:NOVOB) announced on Wednesday the submission of two New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for oral s...
21 March 2019 - - UK-based biotechnology company Bicycle Therapeutics has appointed Pierre Legault, MBA, CPA, as a director and chairman of the board of directors, the company said.

Legau...
20 March 2019 - - US-based biopharmaceutical company vTv Therapeutics Inc. (NASDAQ: VTVT) has entered into a definitive agreement with certain institutional investors for the purchase and sale in a re...
20 March 2019 - - Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that Farxiga (dapagliflozin) reduced the relative risk of major adverse cardiovascula...